Author: Mariah Taylor

A hard-to-diagnose cancer rising in young adults

The rate of appendix cancer has tripled among Generation X and quadrupled among millennials compared to previous generations, a new study found. The study, published June 10 in Annals of Internal Medicine, used the National Cancer Institute’s Surveillance, Epidemiology and…

MD Anderson's 'village' approach to reducing care costs, mortality, length of stay

Traditionally, goals-of-care conversations are reserved for end-of-life care, but The University of Texas MD Anderson Cancer Center is changing that. MD Anderson launched the Center for Goal Concordant Care in 2020. It has one overarching goal, “to ensure we have…

Medicaid expansion expedites lung cancer treatment

Patients in Medicaid expansion states had more timely treatment, a study from the Houston-based University of Texas MD Anderson Cancer Center found. The study, published April 11 in The Annals of Thoracic Surgery, analyzed data from adults ages 40 to…

Cancer-related hospitalizations rise: 5 notes

A recent study found that cancer-related hospitalizations increased 27.3% between 2008 and 2019, resulting in an increased total hospitalization cost of $20.9 billion. The study, published April 18 in Nature Scientific Reports, analyzed National Inpatient Sample data between 2008 and…

Radiation oncology reimbursement bill returns to Congress

A radiation oncology bill aimed at shifting Medicare reimbursements to prioritize quality of care has been reintroduced in Congress.

The advice 3 cancer leaders keep coming back to

Effective leaders commonly have one piece of advice they always come back to. Three cancer center leaders shared with Becker's the wisdom that guides them, from staying curious to loving what you do.

The longest reported case of remission from CAR-T cells

A female patient has been cancer-free for 19 years after being treated with engineered CAR-T cells, making her the longest reported case of cancer remission after this treatment, Nature reported Feb. 17.

The scope of the 'cancer' label debate

In the last year, several cancers have been the subject of debate regarding whether the label of "cancer" should be applied to them.

Another cancer physicians want to nix the label for

Some oncologists are homing in on another cancer they want to see called by other labels: ductal carcinoma in situ, The New York Times reported Jan. 28.

40% of chemotherapy patients have persistent nerve pain: 4 notes

Four in 10 patients treated with chemotherapy experience persistent severe peripheral nerve pain, a recent study found.